Control Bionics Ltd. · ASX:CBL
Control Bionics — Shareholder Meeting (October 2022)
30 slides from Control Bionics's shareholder meeting presentation, Oct 6, 2022
Slide 1: Annual General Meeting October 2022
Control Bionics For personal use only Annual General Meeting October 6 2022 Control Bionics Limited ABN 45 115 465 462
Slide 2: Disclaimer
Disclaimer For personal use only This presentation is intended to provide a general outline only and is not intended to be a de nitive statement on the subject matter covered in it. The information in this presentation, whether written or verbal, has been prepared without taking into account the com
Slide 3: Acknowledgement of Country
Acknowledgement of Country For personal use only I begin today by acknowledging the Gadigal people of the Eora Nation, Traditional Custodians of the land on which we meet today, and pay my respects to their Elders past, present and emerging. I extend that respect to Aboriginal and Torres Strait Isla
Slide 4: Control Bionics Board & Senior Management
Control Bionics Board & Senior Management For personal use only Roger Hawke Rob Wong Peter Ford Brett Crowley Dominik Kucera Non Executive Board Member CEO, Founder & Director Company Secretary CFO Chairman CEO (Resigned) of Innovation Lindsay Phillips Damian Lismore Gillian Shea Non Executive Non E
Slide 5: Agenda
Agenda For personal use only • Board & Management introductions • Proxy Voting • Chair Presentation • Year in Review • Founder/Acting CEO Presentation • CBL Xelerator • Meeting Conclusion & Questions Annual General Meeting | October 6, 2022 5
Slide 6: A Life-Changing Connection
A LIFE-CHANGING CONNECTION
Slide 7: Resolutions & Voting
Resolutions & Voting For personal use only Annual General Meeting | October 6, 2022 7
Slide 8: Presentation Year in Review
For personal use only Presentation Year in Review Annual General Meeting | October 6, 2022 8
Slide 9: Mission
mission For personal use only To be the global leader in innovative augmentative communications and control devices Annual General Meeting | October 6, 2022 9
Slide 10: Product Range 2022
Product Range 2022 For personal use only Annual General Meeting | October 6, 2022 10
Slide 11: Strategic Goals & Achievements
Strategic Goals & Achievements For personal use only • Strategic Priorities • Establish business platform in preparation for post-COVID environment • Expand business in Australia within Assistive Technology space • Expand business in North America within Assistive Technology space • Develop new dist
Slide 12: Summary FY22 Highlights
Summary FY22 Highlights • Revenue of $4.48m. Loss of $6.10m For personal use only FY22 Revenue by Region • 13% YOY growth in revenue despite COVID-19 headwinds • Solid growth in USA Sales 24% • Established operations in Japan • Strong balance sheet with $5.2m in cash as at June 30th 5 0 12 76% -1 4
Slide 13: North America Market Overview
North America Market Overview 5 For personal use only • FY22 Revenue $3.38m. 19% YOY Growth 4 • Made investments in: • Key operational infrastructure & management Revenue (A$m) 3 • Sales and funding team buildup • Marketing awareness activities • Leveraged key reseller partnership with Numotion Grou
Slide 14: Australian Market
Australian Market 2.5 For personal use only 2 • Consistent revenue of $1.12m, despite lockdowns. • Substantial growth forecast for FY23. Revenue (A$m) 1.5 • Investment in: • Sales team buildup • Marketing awareness 1 • Rental plans growing - deferring some revenue • Building relationship with NDIS a
Slide 15: Japanese Market
Japanese Market For personal use only • Ready for Business in Japan • Japanese Language Trilogy Product developed and launched • Branch office established • CBL Founder visit to establish key relationships • Local premium distributor Double R&D appointed • Dedicated sales resource recruited • First
Slide 16: Summary & FY23 Forecast
Summary & FY23 Forecast • Return to double digit revenue growth post COVID-19 For personal use only • Initial Sales in Japan • New target markets in Europe • Continue to manage through global supply chain issues • Continue R&D and test phase for new products 8 0 12 Cash as at 30 June (A$m) Net Loss
Slide 17: CEO Presentation
For personal use only CEO Presentation Annual General Meeting | October 6, 2022 17
Slide 18: Chairman's/CEO Presentation for 2022 Annual General Meeting
Chairman’s/CEO Presentation for 2022 Annual General Meeting For personal use only Control Bionics Limited Date: 6 October 2021 Time: 11am Place: L3, 22 Market Street, Sydney and Virtual Hello everyone, and welcome to the Annual General Meeting of Control Bionics Limited. I am Roger Hawke, the Compan
Slide 19: For personal use only
I am proud of the work the Control Bionics team does every day to tailor Augmentative and Alternative Communications solutions to people in need. Most of us take verbal and non verbal communications for granted in our day to day interactions, but there are a substantial number of people in our commu
Slide 20: For personal use only
We will now move on to a brief presentation. There will be time at the end of the presentation for any questions, and I would ask that you hold your questions until then please. Slide 9 Our mission continues to be to take our market leading technology and apply it to innovative products and services
Slide 21: For personal use only
Despite the slowdown in the rate of growth, the business still achieved revenue growth of 13%, primarily from our US business operations, and the company held $5.2m in cash on the balance sheet as at June 30. Additional cash will flow into the business in FY23 from the exercise of options and repaym
Slide 22: For personal use only
Based on Peter’s recent visit, we are also preparing additional products suitable for the Japanese market to maximise our opportunity there. We also remain in active discussions in several other geographic markets for distribution of our complete systems or alternatively our NeuroNode and Cosmos Con
Slide 23: Annual General Meeting CEO Presentation Script
Annual General Meeting Agenda 2022-10- - CEO Presentation For personal use only Script VO/SOT Time Hello, I’m Peter Ford, founder and CEO of Control SLIDE: CBL logo backdrop 00:00 Bionics, and Director of our new bionics R&D Laboratory CBX. 00:09 Rob Wong joined Control Bionics as CEO five years ago
Slide 24: Script VO/SOT Time
Script VO/SOT Time We are building our devices on a robotic For personal use only production line near our US office - enabling us to evolve designs quickly, and scale up as fast as we can sell… 01:34 … where we once built one unit at a time, the robots are delivering our devices in batches of a hun
Slide 25: Script VO/SOT Time
Script VO/SOT Time This NeuroNode has a spatial sensor that can For personal use only switch on the slightest movement… the lift of an eyebrow or the barest movement of a finger or toe to control communication and other devices. 03:25 And it has Bluetooth to talk to any iPhone, iPad, PC, Mac - and l
Slide 26: Script VO/SOT Time
Script VO/SOT Time The first - Cosmos - represents an entirely new Assistive Technology system empowering a For personal use only disabled person - including children - who can only activate one switch - such as a NeuroNode - to seamlessly switch between learning programs, Android, Apple devices, co
Slide 27: Script VO/SOT Time
Script VO/SOT Time NeuroNode has proven to be a revolutionary new communication system for people with disabilities For personal use only around the world. 06:12 Originally, our first device was the size of a shoebox… now as you know NeuroNode is this small…. wireless, wearable, 24 hour rechargeable
Slide 28: Script VO/SOT Time
Script VO/SOT Time After TWENTY years of developing groundbreaking devices for people with the most For personal use only severe disabilities, our bionic technology is about to help everyone with a common, inevitable disability: growing old. 07:35 We’re designing it not just for people with disabili
Slide 29: Script VO/SOT Time
Script VO/SOT Time A patient who could not move or speak or press a nurse call button - was able to use their For personal use only NeuroNode connected to their iPhone to send a message to the duty nurse’s mobile phone, and ring the phone on the nursing station desk... calling 09:00 for assistance.
Slide 30: Script VO/SOT Time
Script VO/SOT Time It can be controlled with NeuroNode, our eye tracking Trilogy, or voice. 10:25 For personal use only They have also incorporated SafeTrack collision avoidance that stops a chair at any obstacle. 10:30 Initial market testing and user trials are getting enthusiastic support. 10:36 C